"Federal Appeals Court Weighs Fate of Mifepristone in Abortion Access"

A federal appeals court heard arguments over access to mifepristone, a drug commonly used in a two-pill regimen to provide abortion and miscarriage care. The lawsuit over mifepristone dates to November 2022, when a group of abortion rights opponents filed a complaint alleging that the FDA had acted improperly when it approved mifepristone in 2000 and later expanded access to the drug by loosening regulations and allowing it to be dispensed via telehealth. The Fifth Circuit Court of Appeals is once again considering the preliminary injunction that would undo the drug's FDA approval.